Scarica l'app Stockscreener
4.81
12.38%
0.53
Dopo l'orario di chiusura:
5.20
0.39
+8.11%
Precedente Chiudi:
$4.28
Aprire:
$4.28
Volume 24 ore:
86,792
Relative Volume:
0.52
Capitalizzazione di mercato:
$11.23B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+15.90%
1M Prestazione:
+18.77%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.17
$6.146
Intervallo di 1 settimana:
$4.01
$6.146
Portata 52W:
$3.4962
$50.82
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Nome
Radiopharm Theranostics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta RADX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
4.81 | 32.29M | 0 | 0 | 0 | 0.00 |
|
ONC
Beigene Ltd Adr
|
241.43 | 27.03B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 112.64B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 40.86M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 64.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 6.07B | 0 | -153.72M | -103.81M | -2.00 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-12 | Iniziato | B. Riley Securities | Buy |
Radiopharm Theranostics Ltd Adr Borsa (RADX) Ultime notizie
Radiopharm secures lutetium-177 supply agreement By Investing.com - Investing.com South Africa
Radiopharm Theranostics Secures Lutetium-177 Supply Agreement with ITM - TipRanks
Radiopharm secures lutetium-177 supply agreement - Investing.com
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - GlobeNewswire Inc.
Radiopharm advances RAD204 trial with expedited phase By Investing.com - Investing.com India
Radiopharm advances RAD204 trial with expedited phase - Investing.com
RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology - Zacks Small Cap Research
ThinkEquity initiates Radiopharm stock with Buy, $15 target By Investing.com - Investing.com India
ThinkEquity initiates Radiopharm stock with Buy, $15 target - Investing.com
Radiopharm advances brain cancer diagnosis with new trial By Investing.com - Investing.com South Africa
Radiopharm advances brain cancer diagnosis with new trial - Investing.com
Radiopharm Theranostics says new data confirms positive tumour uptake - Biotech Dispatch
Radiopharm Theranostics Engages in Key Healthcare Conferences - TipRanks
B.Riley sets $15 target on Radiopharm Theranostics stock - Investing.com India
Radiopharm Theranostics Announces Director’s Interest Change and Securities Cessation - TipRanks
Radiopharm joins B Riley Radiopharma Conference - Investing.com
Radiopharm reveals positive brain metastases trial data - Investing.com India
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
Radiopharm completes preclinical tests for cancer drug RAD 402 - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com UK
Radiopharm Achieves Nasdaq Listing of American Depositary Shares - GlobeNewswire
Radiopharm Theranostics Set for Nasdaq Debut Under RADX Symbol | RADX Stock News - StockTitan
Radiopharm Theranostics Reports Promising Study Results - MSN
Radiopharm Theranostics (ASX:RAD) Advances Cancer Trials and Expands US Presence - Kalkine Media
Radiopharm Theranostics Marks Progress and Expands US Access - TipRanks
Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited - Business Wire
DBDeutsche Bk Latest Stock News & Market Updates - StockTitan
Market Data Center - Barron's
U.S. STOCKS - The Wall Street Journal
Radiopharm Theranostics Ltd Adr Azioni (RADX) Dati Finanziari
Non sono disponibili dati finanziari per Radiopharm Theranostics Ltd Adr (RADX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
17.27%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):